日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas

FGF7-FGFR2 自分泌信号促进融合阳性横纹肌肉瘤的生长和化学耐药性

Christopher I Milton, Joanna Selfe, Ewa Aladowicz, Stella Y K Man, Carolina Bernauer, Edoardo Missiaglia, Zoë S Walters, Susanne A Gatz, Anna Kelsey, Melanie Generali, Gary Box, Melanie Valenti, Alexis de Haven-Brandon, David Galiwango, Angela Hayes, Matthew Clarke, Elisa Izquierdo, David Gonzalez D

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

口服生物可利用的 CDK9/2 抑制剂在 MYCN 驱动的神经母细胞瘤中显示出基于机制的治疗潜力

Evon Poon, Tong Liang, Yann Jamin, Susanne Walz, Colin Kwok, Anne Hakkert, Karen Barker, Zuzanna Urban, Khin Thway, Rhamy Zeid, Albert Hallsworth, Gary Box, Marli E Ebus, Marco P Licciardello, Yordan Sbirkov, Glori Lazaro, Elizabeth Calton, Barbara M Costa, Melanie Valenti, Alexis De Haven Brandon, 

Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736

耐 Quizartinib 的 FLT3-ITD 急性髓系白血病细胞对 FLT3-Aurora 激酶抑制剂 CCT241736 敏感

Andrew S Moore, Amir Faisal, Grace W Y Mak, Farideh Miraki-Moud, Vassilios Bavetsias, Melanie Valenti, Gary Box, Albert Hallsworth, Alexis de Haven Brandon, Cristina P R Xavier, Randal Stronge, Andrew D J Pearson, Julian Blagg, Florence I Raynaud, Rajesh Chopra, Suzanne A Eccles, David C Taussig, Sp

Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice

鉴定在免疫功能低下的小鼠中作为异种移植瘤表现出雌激素敏感性生长的卵巢高级别浆液性癌细胞系

Alexis De Haven Brandon, Gary Box, Albert Hallsworth, William Court, Nicoll Matthews, Balint Herodek, Aitor Bermejo Arteagabeitia, Melanie Valenti, Vladimir Kirkin

Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy

CCT271850(一种选择性、口服和强效 MPS1 抑制剂)的表征,用于直接测量体内 MPS1 抑制与治疗效果

Amir Faisal, Grace W Y Mak, Mark D Gurden, Cristina P R Xavier, Simon J Anderhub, Paolo Innocenti, Isaac M Westwood, Sébastien Naud, Angela Hayes, Gary Box, Melanie R Valenti, Alexis K De Haven Brandon, Lisa O'Fee, Jessica Schmitt, Hannah L Woodward, Rosemary Burke, Rob L M vanMontfort, Julian Blagg

Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases

评估人类介导复合物相关蛋白激酶调节剂的作用机制和治疗潜力

Paul A Clarke, Maria-Jesus Ortiz-Ruiz, Robert TePoele, Olajumoke Adeniji-Popoola, Gary Box, Will Court, Stephanie Czasch, Samer El Bawab, Christina Esdar, Ken Ewan, Sharon Gowan, Alexis De Haven Brandon, Phillip Hewitt, Stephen M Hobbs, Wolfgang Kaufmann, Aurélie Mallinger, Florence Raynaud, Toby Ro

A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease

用于探索 CDK8 和 CDK19 在人类疾病中的作用的选择性化学探针

Trevor Dale #, Paul A Clarke #, Christina Esdar, Dennis Waalboer, Olajumoke Adeniji-Popoola, Maria-Jesus Ortiz-Ruiz, Aurélie Mallinger, Rahul S Samant, Paul Czodrowski, Djordje Musil, Daniel Schwarz, Klaus Schneider, Mark Stubbs, Ken Ewan, Elizabeth Fraser, Robert TePoele, Will Court, Gary Box, Mela

Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography

利用磁共振弹性成像探索脑恶性肿瘤的生物力学特性及其病理决定因素

Yann Jamin #, Jessica K R Boult #, Jin Li #, Sergey Popov, Philippe Garteiser, Jose L Ulloa, Craig Cummings, Gary Box, Suzanne A Eccles, Chris Jones, John C Waterton, Jeffrey C Bamber, Ralph Sinkus, Simon P Robinson

Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT signaling from a cell-based pathway screen

通过基于细胞的通路筛选发现有效的、口服生物可利用的 WNT 信号小分子抑制剂

Aurélie Mallinger, Simon Crumpler, Mark Pichowicz, Dennis Waalboer, Mark Stubbs, Olajumoke Adeniji-Popoola, Bozena Wood, Elizabeth Smith, Ching Thai, Alan T Henley, Katrin Georgi, William Court, Steve Hobbs, Gary Box, Maria-Jesus Ortiz-Ruiz, Melanie Valenti, Alexis De Haven Brandon, Robert TePoele, 

Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors

发现 3-烷氧基氨基-5-(吡啶-2-基氨基)吡嗪-2-腈作为选择性、口服生物可利用的 CHK1 抑制剂

Michael Lainchbury, Thomas P Matthews, Tatiana McHardy, Kathy J Boxall, Michael I Walton, Paul D Eve, Angela Hayes, Melanie R Valenti, Alexis K de Haven Brandon, Gary Box, G Wynne Aherne, John C Reader, Florence I Raynaud, Suzanne A Eccles, Michelle D Garrett, Ian Collins